Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile. [electronic resource]
Producer: 20171221Description: 205-215 p. digitalISSN:- 1096-1186
- Animals
- Binding Sites
- Blood-Brain Barrier -- metabolism
- Brain -- drug effects
- Brain Injuries -- drug therapy
- Cannabinoid Receptor Agonists -- chemical synthesis
- Cell Line
- Disease Models, Animal
- Humans
- Isoxazoles -- chemical synthesis
- Male
- Malonates
- Mice
- Models, Biological
- Nerve Degeneration
- Neurons -- drug effects
- Neuroprotective Agents -- chemical synthesis
- Permeability
- Protein Binding
- Rats, Wistar
- Receptor, Cannabinoid, CB2 -- agonists
- Transfection
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.